The FDA has proposed banning oral phenylephrine, often found in decongestants. The ban is due to its lack of effectiveness, not safety. Several popular cold medications contain this ingredient, but the ban does not affect nasal spray phenylephrine. Companies can continue selling products with oral phenylephrine until the ban is finalized, but will need to remove or reformulate them afterwards. Consumers are urged to check medication labels and consider alternative treatments. The FDA emphasizes the importance of safe and effective drugs and expects manufacturers to transition accordingly. The CHPA opposes the ban, citing consumer preference for phenylephrine as a decongestant.
Source link
FDA Proposes To Ban Popular Decongestant In Cold Medicines Citing ‘Not Effective’
